Angiogenesis in cancer and other diseases

Peter Carmeliet () and Rakesh K. Jain ()
Additional contact information
Peter Carmeliet: The Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology
Rakesh K. Jain: Massachusetts General Hospital and Harvard Medical School

Nature, 2000, vol. 407, issue 6801, 249-257

Abstract: Abstract Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.

Date: 2000
References: Add references at CitEc
Citations: View citations in EconPapers (13)

Downloads: (external link)
https://www.nature.com/articles/35025220 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:407:y:2000:i:6801:d:10.1038_35025220

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35025220

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().